Barbara A. Yastine
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Barlow Lowers Alkami Target to $15; AI and Fraud News. Barclays cut its price target for Alkami to $15 while keeping an Equal-Weight rating. The company also highlighted how its platform helped customers prevent over $263 million in fraud and discussed new AI governance tools for banks. These updates show Alkami is focusing on security and AI adoption, though the lower analyst target reflects cautious expectations.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Zions Bancorp Analysts Cut Targets Amid Fed Policy Shift. Several major banks lowered their price targets for Zions Bancorp, with JP Morgan, Evercore ISI, and Piper Sandler all reducing expectations to the mid‑$60s. The cuts come as the Fed considers raising asset thresholds, which could tighten regulatory capital for regional banks. Despite the downward revisions, Zions has posted a 14.8% gain over the past six months and remains near its 200‑day moving‑average support at $61.72.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS cites multiple drivers for Axis Capital growth. UBS recently noted that Axis Capital is positioned for growth that could exceed market averages, citing multiple drivers. The company also highlighted its specialty focus as a support for shareholder returns. Investors are currently awaiting third-quarter financial results scheduled for release on October 28, 2026.
Transaction History
| PRI | ▲ Buy | Grant | 56 | $16K | 9/14/2026 | View on chart |
| PRI | ▲ Buy | Grant | 58 | $16K | 6/12/2026 | View on chart |
| PRI | ▲ Buy | Grant | 640 | $180K | 5/21/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 11,357 | $0 | 5/19/2026 | View on chart |
| ZION | ▲ Buy | Grant | 2,055 | $130K | 5/1/2026 | View on chart |
| PRI | ▲ Buy | Grant | 65 | $16K | 3/13/2026 | View on chart |
| AXS | ▲ Buy | Grant | 1,594 | — | 1/15/2026 | View on chart |
| PRI | ▲ Buy | Grant | 54 | $14K | 12/15/2025 | View on chart |
| PRI | ▲ Buy | Grant | 51 | $14K | 9/15/2025 | View on chart |
| PRI | ▲ Buy | Grant | 53 | $14K | 6/13/2025 | View on chart |
| PRI | ▲ Buy | Grant | 552 | $150K | 5/14/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 7,225 | $0 | 5/14/2025 | View on chart |
| ZION | ▲ Buy | Grant | 2,789 | $130K | 5/2/2025 | View on chart |
| PRI | ▲ Buy | Grant | 50 | $14K | 3/14/2025 | View on chart |
| AXS | ▲ Buy | Grant | 1,665 | — | 1/16/2025 | View on chart |
| PRI | ▲ Buy | Grant | 42 | $12K | 12/12/2024 | View on chart |
| PRI | ▲ Buy | Grant | 48 | $12K | 9/12/2024 | View on chart |
| PRI | ▲ Buy | Grant | 45 | $10K | 6/12/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 6,853 | $0 | 5/15/2024 | View on chart |
| PRI | ▲ Buy | Grant | 684 | $150K | 5/8/2024 | View on chart |
| ZION | ▲ Buy | Grant | 2,874 | $120K | 4/26/2024 | View on chart |
| PRI | ▲ Buy | Grant | 40 | $10K | 3/12/2024 | View on chart |
| AXS | ▲ Buy | Grant | 5,343 | — | 1/16/2024 | View on chart |
| PRI | ▲ Buy | Grant | 40 | $8K | 12/12/2023 | View on chart |
| PRI | ▲ Buy | Grant | 42 | $8K | 9/11/2023 | View on chart |
| PRI | ▲ Buy | Grant | 44 | $8K | 6/12/2023 | View on chart |
| PRI | ▲ Buy | Grant | 720 | $130K | 5/17/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 13,699 | $0 | 5/17/2023 | View on chart |
| ZION | ▲ Buy | Grant | 4,419 | $105K | 5/5/2023 | View on chart |
| PRI | ▲ Buy | Grant | 52 | $8K | 3/14/2023 | View on chart |
| AXS | ▲ Buy | Grant | 2,661 | — | 1/17/2023 | View on chart |
| PRI | ▲ Buy | Grant | 50 | $7K | 12/14/2022 | View on chart |
| PRI | ▲ Buy | Grant | 55 | $7K | 9/14/2022 | View on chart |
| PRI | ▲ Buy | Grant | 61 | $7K | 6/14/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 14,179 | $0 | 5/18/2022 | View on chart |
| PRI | ▲ Buy | Grant | 1,090 | $130K | 5/11/2022 | View on chart |
| ZION | ▲ Buy | Grant | 1,858 | $105K | 4/29/2022 | View on chart |
| PRI | ▲ Buy | Grant | 55 | $7K | 3/14/2022 | View on chart |
| AXS | ▲ Buy | Grant | 1,754 | — | 1/14/2022 | View on chart |
| PRI | ▲ Buy | Grant | 40 | $6K | 12/14/2021 | View on chart |
| PRI | ▲ Buy | Grant | 40 | $6K | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Primerica reports modest improvement in middle-income purchasing power
Primerica's latest Household Budget Index indicates that middle-income Americans are experiencing a slight increase in purchasing power as of August. This data point is relevant to the company's core business, as it suggests a stable or improving financial environment for its target customer base. The stock is currently trading near its 52-week low, with an RSI of 37.3, indicating it is in a neutral-to-oversold zone.
Primerica reports modest improvement in middle-income purchasing power. Primerica's latest Household Budget Index indicates that middle-income Americans are experiencing a slight increase in purchasing power as of August. This data point is relevant to the company's core business, as it suggests a stable or improving financial environment for its target customer base. The stock is currently trading near its 52-week low, with an RSI of 37.3, indicating it is in a neutral-to-oversold zone.